In early stage colon cancer, the TGFβ super family is growth suppressive, while in advanced disease, high serum and stroma levels of TGFβ are associated with poor prognosis in colon cancer [102, 103] and in pancreatic cancers [104]. This evidence concerns the gene TGFB1 and colonic neoplasm.